Georgia Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 28 (80% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 27,763
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 60.20%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 9,728
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 56.78%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 37.98% 41.84%
White, Hispanic/Latino Patients 7.81% 7.61%
Black/African American, Non-Hispanic/Latino Patients 44.96% 42.99%
Black/African American, Hispanic/Latino Patients 0.28% 0.28%
Asian Patients3 1.04% 0.95%
American Indian/Alaska Native Patients3 0.35% 0.25%
Native Hawaiian/Other Pacific Islander Patients3 0.10% 0.05%
Patients with More Than One Race3 1.75% 1.71%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.15% 1.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.31% 0.88%
Unreported/Refused to Report Race and Ethnicity 2.29% 2.31%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,087
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 79.28%
COVID-19 Immunization Series Completed 826
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 84.06%
COVID-19 Immunization Series Additional 2,360
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 71.01%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 20.06% 15.01% 27.88%
White, Hispanic/Latino Patients 16.74% 14.16% 13.60%
Black/African American, Non-Hispanic/Latino Patients 51.70% 55.81% 41.65%
Black/African American, Hispanic/Latino Patients 1.10% 1.33% 0.85%
Asian Patients3 0.92% 2.06% 2.42%
American Indian/Alaska Native Patients3 0.46% 1.33% 8.05%
Native Hawaiian/Other Pacific Islander Patients3 0.09% 0.24% 0.08%
Patients with More Than One Race3 1.10% 1.69% 0.47%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.60% 2.54% 1.19%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.37% 0.61% 0.59%
Unreported/Refused to Report Race and Ethnicity 2.85% 5.21% 3.22%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 17.86%
1 to 24 Hours 21.43%
More Than 24 Hours 60.71%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 50.00%
Vaccine confidence 32.14%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 3.57%
None 25.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 17.86%
Average Percent of Health Center Visits Conducted Virtually 9.64%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 32.14%
Number of Mobile Van Sites 4
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 3
Number of Family Vaccination Clinics 11

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 7.14%
Refer patients to another organization that provides monoclonal antibody therapies 57.14%
None 35.71%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.14%
Patient awareness/education 7.14%
Staffing capacity 25.00%
Therapy administration/onsite logistics 14.29%
Other 3.57%
None 64.29%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 5
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 23,061

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 80.00%
Provide to General Public Who Came to the Health Center 80.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 60.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 40.00%
Other 40.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 0.00%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 66.67%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022